233 related articles for article (PubMed ID: 17135587)
41. Beyond menopause. Life after estrogen.
Mayo Clin Health Lett; 2005 Feb; Suppl():1-8. PubMed ID: 15732174
[No Abstract] [Full Text] [Related]
42. Effects of estrogen plus progestin on health-related quality of life.
Lopes AA; Latado A; Lopes GB
N Engl J Med; 2004 Feb; 350(6):622. PubMed ID: 14762196
[No Abstract] [Full Text] [Related]
43. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies.
Keenan NL; Mark S; Fugh-Berman A; Browne D; Kaczmarczyk J; Hunter C
Menopause; 2003; 10(6):507-15. PubMed ID: 14627858
[TBL] [Abstract][Full Text] [Related]
44. Treatment of menopausal vasomotor symptoms.
Obstet Gynecol; 2005 May; 105(5 Pt 1):1137-9. PubMed ID: 15863558
[No Abstract] [Full Text] [Related]
45. Managing urogenital atrophy.
Palacios S
Maturitas; 2009 Aug; 63(4):315-8. PubMed ID: 19493638
[TBL] [Abstract][Full Text] [Related]
46. Estrasorb.
Chiechi LM
IDrugs; 2004 Sep; 7(9):860-4. PubMed ID: 15470604
[TBL] [Abstract][Full Text] [Related]
47. [Treatment with E ovules in postmenopausal colpocystopathies].
Pricop F; Teleman G; Buţureanu S; Căzănaru R; Gafiţanu E; Popovici I
Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):353-5. PubMed ID: 3685702
[No Abstract] [Full Text] [Related]
48. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
Mortimer JE
Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
[TBL] [Abstract][Full Text] [Related]
49. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
Crandall C
J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
[TBL] [Abstract][Full Text] [Related]
50. Current management of menopausal symptoms in cancer patients.
Barton DL; Loprinzi C; Gostout B
Oncology (Williston Park); 2002 Jan; 16(1):67-72, 74; discussion 75-6, 79-80. PubMed ID: 11831612
[TBL] [Abstract][Full Text] [Related]
51. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
Shulman LP
J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
[No Abstract] [Full Text] [Related]
52. Progestins and recurrence in breast cancer survivors.
Chlebowski RT; Anderson GL
J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
[No Abstract] [Full Text] [Related]
53. A tissue selective estrogen complex: a new horizon for menopausal symptoms.
Warren MP
Menopause; 2009; 16(6):1083-4. PubMed ID: 19745771
[No Abstract] [Full Text] [Related]
54. Menopausal hormone replacement therapy in dermatology.
Danby FW
JAMA Dermatol; 2014 Dec; 150(12):1261-2. PubMed ID: 25250584
[No Abstract] [Full Text] [Related]
55. Hormone therapy. An update on risks and benefits.
Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
[No Abstract] [Full Text] [Related]
56. An overview of chronic vaginal atrophy and options for symptom management.
Woods NF
Nurs Womens Health; 2012 Dec; 16(6):482-93; quiz 494. PubMed ID: 23253575
[TBL] [Abstract][Full Text] [Related]
57. [Indications for and practical aspects of intravaginal estrogen therapy using dienoestrol ortho-vaginal cream].
Korte W
Fortschr Med; 1973 Aug; 91(22):921-8. PubMed ID: 4744899
[No Abstract] [Full Text] [Related]
58. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
Seifert-Klauss V; Kingwell E; Hitchcock CL; Kalyan S; Prior JC
Menopause; 2008; 15(1):203; author reply 203-4. PubMed ID: 18182940
[No Abstract] [Full Text] [Related]
59. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
Archer DF
Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205
[TBL] [Abstract][Full Text] [Related]
60. Management of hot flashes in menopausal women.
Johnson L; Clem JR
S D Med; 2013 Sep; 66(9):376-7. PubMed ID: 24279114
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
